AMNEAL PHARMACEUTICALS ($AMRX) posted quarterly earnings results on Friday, February 28th. The company reported earnings of $0.12 per share, missing estimates of $0.16 by $0.04. The company also reported revenue of $730,520,000, beating estimates of $721,703,550 by $8,816,450.
You can see Quiver Quantitative's $AMRX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMNEAL PHARMACEUTICALS Insider Trading Activity
AMNEAL PHARMACEUTICALS insiders have traded $AMRX stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $AMRX stock by insiders over the last 6 months:
- GAUTAM PATEL has made 0 purchases and 3 sales selling 160,000 shares for an estimated $1,292,000.
- JASON B. DALY (SVP, Chief Legal Officer) has made 0 purchases and 2 sales selling 57,322 shares for an estimated $490,672.
- DEBORAH M. AUTOR has made 0 purchases and 2 sales selling 40,000 shares for an estimated $334,073.
- JOHN KIELY sold 17,058 shares for an estimated $142,946
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMNEAL PHARMACEUTICALS Hedge Fund Activity
We have seen 117 institutional investors add shares of AMNEAL PHARMACEUTICALS stock to their portfolio, and 86 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 20,107,524 shares (-92.4%) from their portfolio in Q4 2024, for an estimated $159,251,590
- FOSUN INTERNATIONAL LTD removed 1,720,855 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $13,629,171
- LSV ASSET MANAGEMENT removed 1,057,300 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $8,796,736
- WOODLINE PARTNERS LP removed 1,037,471 shares (-64.7%) from their portfolio in Q4 2024, for an estimated $8,216,770
- NANTAHALA CAPITAL MANAGEMENT, LLC added 995,586 shares (+37.3%) to their portfolio in Q4 2024, for an estimated $7,885,041
- PHOCAS FINANCIAL CORP. removed 813,301 shares (-80.1%) from their portfolio in Q4 2024, for an estimated $6,441,343
- SANDERS MORRIS HARRIS LLC removed 567,196 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $4,719,070
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMNEAL PHARMACEUTICALS Government Contracts
We have seen $173,571 of award payments to $AMRX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- XYREM (SODIUM OXYBATE) ORAL SOLUTION.: $173,571
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
